Filing Details
- Accession Number:
- 0001209191-15-021526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 17:26:47
- Reporting Period:
- 2015-03-01
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 17:26:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1330401 | Jason Hannon | 7475 Lusk Blvd San Diego CA 92121 | Evp, General Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-01 | 7,756 | $0.00 | 57,020 | No | 4 | A | Direct | |
Common Stock | Disposition | 2015-03-01 | 4,047 | $45.75 | 52,973 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-02 | 5,085 | $45.06 | 47,888 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Settlement of vested shares under Performance Restricted Stock Unit ("PRSU") grant dated February 13, 2012.
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
- Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting/settlement of PRSUs dated February 13, 2012.
- Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on November 14, 2014, which is intended to comply with Rule 10b5-1.
- Weighted average from 42 transactions with prices ranging from $44.4300 to $45.9100. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.